Better make sure its covered by your malpractice policy, accessed December 19, 2025, GLP-1 Med Spa Insurance Exclusions: What You Need to Know Before Administering Weight Loss Injections, accessed December 19, 2025, GLP1 Informed Consent Superpower, accessed December 19, 2025, Lillys three-pronged drug puts obesity field on notice | BioPharma Dive, accessed December 19, 2025, Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP1 and amylin analogues for weight management PR Newswire, accessed December 19, 2025, FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, accessed December 19, 2025,
The relationship between other comorbidities such as rhinitis [52] and gastroesophageal reflux disease (GERD) [53] with OSA may be significant factors in poor asthma control in these patients as well [54]
Although side effects may be more likely, most situations can be managed safely with the right precautions and medical guidance when needed
However, this is a narrative assembled from four independent bodies of preclinical research
Mashayekhi M, Beckman JA, Nian H, Garner EM, Mayfield D, Devin JK, et al
